The store will not work correctly when cookies are disabled.
2-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-5-phenyl-1,3,4-oxadiazole
ID: ALA3099510
PubChem CID: 72946868
Max Phase: Preclinical
Molecular Formula: C24H18N4O
Molecular Weight: 378.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c(-c2nnc(-c3ccccc3)o2)c(-c2ccccc2)nn1-c1ccccc1
Standard InChI: InChI=1S/C24H18N4O/c1-17-21(24-26-25-23(29-24)19-13-7-3-8-14-19)22(18-11-5-2-6-12-18)27-28(17)20-15-9-4-10-16-20/h2-16H,1H3
Standard InChI Key: FAASHEWRVGPSGI-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
23.9210 -3.3430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1038 -3.3389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8474 -4.1148 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5061 -4.5985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1696 -4.1215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5012 -5.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7899 -5.8172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7854 -6.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4916 -7.0465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2037 -6.6371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2047 -5.8220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9455 -4.3779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6291 -2.6773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9669 -1.9320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4907 -1.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6766 -1.3498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3411 -2.0996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8194 -2.7596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4042 -2.6871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2214 -2.6912 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4779 -1.9153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8191 -1.4316 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1557 -1.9087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2566 -1.6674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8610 -2.2190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6388 -1.9710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8134 -1.1718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2040 -0.6210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4285 -0.8719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 6 1 0
5 12 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
2 13 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 2 0
1 19 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
21 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 378.44 | Molecular Weight (Monoisotopic): 378.1481 | AlogP: 5.56 | #Rotatable Bonds: 4 |
Polar Surface Area: 56.74 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 1.31 | CX LogP: 5.32 | CX LogD: 5.32 |
Aromatic Rings: 5 | Heavy Atoms: 29 | QED Weighted: 0.41 | Np Likeness Score: -1.17 |
References
1. Ningaiah S, Bhadraiah UK, Doddaramappa SD, Keshavamurthy S, Javarasetty C.. (2014) Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation., 24 (1): [PMID:24316123] [10.1016/j.bmcl.2013.11.029] |